Global Parkinson's Disease Treatments Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Parkinson's Disease Treatments market size was valued at US$ million in 2023. With growing demand in downstream market, the Parkinson's Disease Treatments is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Parkinson's Disease Treatments market. Parkinson's Disease Treatments are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Parkinson's Disease Treatments. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Parkinson's Disease Treatments market.
Parkinson’s disease is a central nervous system syndrome which affects the motor neuron, mainly characterized by rigidity, tremor, depression, dementia, and so on. Treatment for this disease is mostly symptomatic and almost no curative treatment alternatives are available.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Parkinson's Disease Treatments market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Parkinson's Disease Treatments market. It may include historical data, market segmentation by Type (e.g., Dopamine Agonists, Levodopa), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Parkinson's Disease Treatments market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Parkinson's Disease Treatments market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Parkinson's Disease Treatments industry. This include advancements in Parkinson's Disease Treatments technology, Parkinson's Disease Treatments new entrants, Parkinson's Disease Treatments new investment, and other innovations that are shaping the future of Parkinson's Disease Treatments.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Parkinson's Disease Treatments market. It includes factors influencing customer ' purchasing decisions, preferences for Parkinson's Disease Treatments product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Parkinson's Disease Treatments market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Parkinson's Disease Treatments market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Parkinson's Disease Treatments market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Parkinson's Disease Treatments industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Parkinson's Disease Treatments market.
Market Segmentation:
Parkinson's Disease Treatments market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Parkinson's Disease Treatments market size was valued at US$ million in 2023. With growing demand in downstream market, the Parkinson's Disease Treatments is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Parkinson's Disease Treatments market. Parkinson's Disease Treatments are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Parkinson's Disease Treatments. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Parkinson's Disease Treatments market.
Parkinson’s disease is a central nervous system syndrome which affects the motor neuron, mainly characterized by rigidity, tremor, depression, dementia, and so on. Treatment for this disease is mostly symptomatic and almost no curative treatment alternatives are available.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Parkinson's Disease Treatments market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Parkinson's Disease Treatments market. It may include historical data, market segmentation by Type (e.g., Dopamine Agonists, Levodopa), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Parkinson's Disease Treatments market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Parkinson's Disease Treatments market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Parkinson's Disease Treatments industry. This include advancements in Parkinson's Disease Treatments technology, Parkinson's Disease Treatments new entrants, Parkinson's Disease Treatments new investment, and other innovations that are shaping the future of Parkinson's Disease Treatments.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Parkinson's Disease Treatments market. It includes factors influencing customer ' purchasing decisions, preferences for Parkinson's Disease Treatments product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Parkinson's Disease Treatments market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Parkinson's Disease Treatments market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Parkinson's Disease Treatments market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Parkinson's Disease Treatments industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Parkinson's Disease Treatments market.
Market Segmentation:
Parkinson's Disease Treatments market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Dopamine Agonists
- Levodopa
- Glutamate Antagonist
- Apomorphine
- COMT Inhibitors Anticholinergics
- MAO-B Inhibitors
- Other Drugs
- Hospitals
- Healthcare Institutes
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- Merck
- Novartis
- Teva
- Boehringer Ingelheim
- Impax
- Abbvie
- Bausch Health
- Lundbeck
- Sun Pharma
- Wockhardt
- Acadia
- UCB
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Parkinson's Disease Treatments Market Size 2019-2030
2.1.2 Parkinson's Disease Treatments Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Parkinson's Disease Treatments Segment by Type
2.2.1 Dopamine Agonists
2.2.2 Levodopa
2.2.3 Glutamate Antagonist
2.2.4 Apomorphine
2.2.5 COMT Inhibitors Anticholinergics
2.2.6 MAO-B Inhibitors
2.2.7 Other Drugs
2.3 Parkinson's Disease Treatments Market Size by Type
2.3.1 Parkinson's Disease Treatments Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Parkinson's Disease Treatments Market Size Market Share by Type (2019-2024)
2.4 Parkinson's Disease Treatments Segment by Application
2.4.1 Hospitals
2.4.2 Healthcare Institutes
2.4.3 Others
2.5 Parkinson's Disease Treatments Market Size by Application
2.5.1 Parkinson's Disease Treatments Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Parkinson's Disease Treatments Market Size Market Share by Application (2019-2024)
3 PARKINSON'S DISEASE TREATMENTS MARKET SIZE BY PLAYER
3.1 Parkinson's Disease Treatments Market Size Market Share by Players
3.1.1 Global Parkinson's Disease Treatments Revenue by Players (2019-2024)
3.1.2 Global Parkinson's Disease Treatments Revenue Market Share by Players (2019-2024)
3.2 Global Parkinson's Disease Treatments Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PARKINSON'S DISEASE TREATMENTS BY REGIONS
4.1 Parkinson's Disease Treatments Market Size by Regions (2019-2024)
4.2 Americas Parkinson's Disease Treatments Market Size Growth (2019-2024)
4.3 APAC Parkinson's Disease Treatments Market Size Growth (2019-2024)
4.4 Europe Parkinson's Disease Treatments Market Size Growth (2019-2024)
4.5 Middle East & Africa Parkinson's Disease Treatments Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Parkinson's Disease Treatments Market Size by Country (2019-2024)
5.2 Americas Parkinson's Disease Treatments Market Size by Type (2019-2024)
5.3 Americas Parkinson's Disease Treatments Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parkinson's Disease Treatments Market Size by Region (2019-2024)
6.2 APAC Parkinson's Disease Treatments Market Size by Type (2019-2024)
6.3 APAC Parkinson's Disease Treatments Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Parkinson's Disease Treatments by Country (2019-2024)
7.2 Europe Parkinson's Disease Treatments Market Size by Type (2019-2024)
7.3 Europe Parkinson's Disease Treatments Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Parkinson's Disease Treatments by Region (2019-2024)
8.2 Middle East & Africa Parkinson's Disease Treatments Market Size by Type (2019-2024)
8.3 Middle East & Africa Parkinson's Disease Treatments Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PARKINSON'S DISEASE TREATMENTS MARKET FORECAST
10.1 Global Parkinson's Disease Treatments Forecast by Regions (2025-2030)
10.1.1 Global Parkinson's Disease Treatments Forecast by Regions (2025-2030)
10.1.2 Americas Parkinson's Disease Treatments Forecast
10.1.3 APAC Parkinson's Disease Treatments Forecast
10.1.4 Europe Parkinson's Disease Treatments Forecast
10.1.5 Middle East & Africa Parkinson's Disease Treatments Forecast
10.2 Americas Parkinson's Disease Treatments Forecast by Country (2025-2030)
10.2.1 United States Parkinson's Disease Treatments Market Forecast
10.2.2 Canada Parkinson's Disease Treatments Market Forecast
10.2.3 Mexico Parkinson's Disease Treatments Market Forecast
10.2.4 Brazil Parkinson's Disease Treatments Market Forecast
10.3 APAC Parkinson's Disease Treatments Forecast by Region (2025-2030)
10.3.1 China Parkinson's Disease Treatments Market Forecast
10.3.2 Japan Parkinson's Disease Treatments Market Forecast
10.3.3 Korea Parkinson's Disease Treatments Market Forecast
10.3.4 Southeast Asia Parkinson's Disease Treatments Market Forecast
10.3.5 India Parkinson's Disease Treatments Market Forecast
10.3.6 Australia Parkinson's Disease Treatments Market Forecast
10.4 Europe Parkinson's Disease Treatments Forecast by Country (2025-2030)
10.4.1 Germany Parkinson's Disease Treatments Market Forecast
10.4.2 France Parkinson's Disease Treatments Market Forecast
10.4.3 UK Parkinson's Disease Treatments Market Forecast
10.4.4 Italy Parkinson's Disease Treatments Market Forecast
10.4.5 Russia Parkinson's Disease Treatments Market Forecast
10.5 Middle East & Africa Parkinson's Disease Treatments Forecast by Region (2025-2030)
10.5.1 Egypt Parkinson's Disease Treatments Market Forecast
10.5.2 South Africa Parkinson's Disease Treatments Market Forecast
10.5.3 Israel Parkinson's Disease Treatments Market Forecast
10.5.4 Turkey Parkinson's Disease Treatments Market Forecast
10.5.5 GCC Countries Parkinson's Disease Treatments Market Forecast
10.6 Global Parkinson's Disease Treatments Forecast by Type (2025-2030)
10.7 Global Parkinson's Disease Treatments Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Parkinson's Disease Treatments Product Offered
11.1.3 GSK Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 GSK Main Business Overview
11.1.5 GSK Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Parkinson's Disease Treatments Product Offered
11.2.3 Merck Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Parkinson's Disease Treatments Product Offered
11.3.3 Novartis Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Teva
11.4.1 Teva Company Information
11.4.2 Teva Parkinson's Disease Treatments Product Offered
11.4.3 Teva Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Teva Main Business Overview
11.4.5 Teva Latest Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim Parkinson's Disease Treatments Product Offered
11.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Boehringer Ingelheim Main Business Overview
11.5.5 Boehringer Ingelheim Latest Developments
11.6 Impax
11.6.1 Impax Company Information
11.6.2 Impax Parkinson's Disease Treatments Product Offered
11.6.3 Impax Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Impax Main Business Overview
11.6.5 Impax Latest Developments
11.7 Abbvie
11.7.1 Abbvie Company Information
11.7.2 Abbvie Parkinson's Disease Treatments Product Offered
11.7.3 Abbvie Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Abbvie Main Business Overview
11.7.5 Abbvie Latest Developments
11.8 Bausch Health
11.8.1 Bausch Health Company Information
11.8.2 Bausch Health Parkinson's Disease Treatments Product Offered
11.8.3 Bausch Health Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bausch Health Main Business Overview
11.8.5 Bausch Health Latest Developments
11.9 Lundbeck
11.9.1 Lundbeck Company Information
11.9.2 Lundbeck Parkinson's Disease Treatments Product Offered
11.9.3 Lundbeck Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Lundbeck Main Business Overview
11.9.5 Lundbeck Latest Developments
11.10 Sun Pharma
11.10.1 Sun Pharma Company Information
11.10.2 Sun Pharma Parkinson's Disease Treatments Product Offered
11.10.3 Sun Pharma Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Sun Pharma Main Business Overview
11.10.5 Sun Pharma Latest Developments
11.11 Wockhardt
11.11.1 Wockhardt Company Information
11.11.2 Wockhardt Parkinson's Disease Treatments Product Offered
11.11.3 Wockhardt Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Wockhardt Main Business Overview
11.11.5 Wockhardt Latest Developments
11.12 Acadia
11.12.1 Acadia Company Information
11.12.2 Acadia Parkinson's Disease Treatments Product Offered
11.12.3 Acadia Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Acadia Main Business Overview
11.12.5 Acadia Latest Developments
11.13 UCB
11.13.1 UCB Company Information
11.13.2 UCB Parkinson's Disease Treatments Product Offered
11.13.3 UCB Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 UCB Main Business Overview
11.13.5 UCB Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Parkinson's Disease Treatments Market Size 2019-2030
2.1.2 Parkinson's Disease Treatments Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Parkinson's Disease Treatments Segment by Type
2.2.1 Dopamine Agonists
2.2.2 Levodopa
2.2.3 Glutamate Antagonist
2.2.4 Apomorphine
2.2.5 COMT Inhibitors Anticholinergics
2.2.6 MAO-B Inhibitors
2.2.7 Other Drugs
2.3 Parkinson's Disease Treatments Market Size by Type
2.3.1 Parkinson's Disease Treatments Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Parkinson's Disease Treatments Market Size Market Share by Type (2019-2024)
2.4 Parkinson's Disease Treatments Segment by Application
2.4.1 Hospitals
2.4.2 Healthcare Institutes
2.4.3 Others
2.5 Parkinson's Disease Treatments Market Size by Application
2.5.1 Parkinson's Disease Treatments Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Parkinson's Disease Treatments Market Size Market Share by Application (2019-2024)
3 PARKINSON'S DISEASE TREATMENTS MARKET SIZE BY PLAYER
3.1 Parkinson's Disease Treatments Market Size Market Share by Players
3.1.1 Global Parkinson's Disease Treatments Revenue by Players (2019-2024)
3.1.2 Global Parkinson's Disease Treatments Revenue Market Share by Players (2019-2024)
3.2 Global Parkinson's Disease Treatments Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PARKINSON'S DISEASE TREATMENTS BY REGIONS
4.1 Parkinson's Disease Treatments Market Size by Regions (2019-2024)
4.2 Americas Parkinson's Disease Treatments Market Size Growth (2019-2024)
4.3 APAC Parkinson's Disease Treatments Market Size Growth (2019-2024)
4.4 Europe Parkinson's Disease Treatments Market Size Growth (2019-2024)
4.5 Middle East & Africa Parkinson's Disease Treatments Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Parkinson's Disease Treatments Market Size by Country (2019-2024)
5.2 Americas Parkinson's Disease Treatments Market Size by Type (2019-2024)
5.3 Americas Parkinson's Disease Treatments Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parkinson's Disease Treatments Market Size by Region (2019-2024)
6.2 APAC Parkinson's Disease Treatments Market Size by Type (2019-2024)
6.3 APAC Parkinson's Disease Treatments Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Parkinson's Disease Treatments by Country (2019-2024)
7.2 Europe Parkinson's Disease Treatments Market Size by Type (2019-2024)
7.3 Europe Parkinson's Disease Treatments Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Parkinson's Disease Treatments by Region (2019-2024)
8.2 Middle East & Africa Parkinson's Disease Treatments Market Size by Type (2019-2024)
8.3 Middle East & Africa Parkinson's Disease Treatments Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PARKINSON'S DISEASE TREATMENTS MARKET FORECAST
10.1 Global Parkinson's Disease Treatments Forecast by Regions (2025-2030)
10.1.1 Global Parkinson's Disease Treatments Forecast by Regions (2025-2030)
10.1.2 Americas Parkinson's Disease Treatments Forecast
10.1.3 APAC Parkinson's Disease Treatments Forecast
10.1.4 Europe Parkinson's Disease Treatments Forecast
10.1.5 Middle East & Africa Parkinson's Disease Treatments Forecast
10.2 Americas Parkinson's Disease Treatments Forecast by Country (2025-2030)
10.2.1 United States Parkinson's Disease Treatments Market Forecast
10.2.2 Canada Parkinson's Disease Treatments Market Forecast
10.2.3 Mexico Parkinson's Disease Treatments Market Forecast
10.2.4 Brazil Parkinson's Disease Treatments Market Forecast
10.3 APAC Parkinson's Disease Treatments Forecast by Region (2025-2030)
10.3.1 China Parkinson's Disease Treatments Market Forecast
10.3.2 Japan Parkinson's Disease Treatments Market Forecast
10.3.3 Korea Parkinson's Disease Treatments Market Forecast
10.3.4 Southeast Asia Parkinson's Disease Treatments Market Forecast
10.3.5 India Parkinson's Disease Treatments Market Forecast
10.3.6 Australia Parkinson's Disease Treatments Market Forecast
10.4 Europe Parkinson's Disease Treatments Forecast by Country (2025-2030)
10.4.1 Germany Parkinson's Disease Treatments Market Forecast
10.4.2 France Parkinson's Disease Treatments Market Forecast
10.4.3 UK Parkinson's Disease Treatments Market Forecast
10.4.4 Italy Parkinson's Disease Treatments Market Forecast
10.4.5 Russia Parkinson's Disease Treatments Market Forecast
10.5 Middle East & Africa Parkinson's Disease Treatments Forecast by Region (2025-2030)
10.5.1 Egypt Parkinson's Disease Treatments Market Forecast
10.5.2 South Africa Parkinson's Disease Treatments Market Forecast
10.5.3 Israel Parkinson's Disease Treatments Market Forecast
10.5.4 Turkey Parkinson's Disease Treatments Market Forecast
10.5.5 GCC Countries Parkinson's Disease Treatments Market Forecast
10.6 Global Parkinson's Disease Treatments Forecast by Type (2025-2030)
10.7 Global Parkinson's Disease Treatments Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Parkinson's Disease Treatments Product Offered
11.1.3 GSK Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 GSK Main Business Overview
11.1.5 GSK Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Parkinson's Disease Treatments Product Offered
11.2.3 Merck Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Parkinson's Disease Treatments Product Offered
11.3.3 Novartis Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Teva
11.4.1 Teva Company Information
11.4.2 Teva Parkinson's Disease Treatments Product Offered
11.4.3 Teva Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Teva Main Business Overview
11.4.5 Teva Latest Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim Parkinson's Disease Treatments Product Offered
11.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Boehringer Ingelheim Main Business Overview
11.5.5 Boehringer Ingelheim Latest Developments
11.6 Impax
11.6.1 Impax Company Information
11.6.2 Impax Parkinson's Disease Treatments Product Offered
11.6.3 Impax Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Impax Main Business Overview
11.6.5 Impax Latest Developments
11.7 Abbvie
11.7.1 Abbvie Company Information
11.7.2 Abbvie Parkinson's Disease Treatments Product Offered
11.7.3 Abbvie Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Abbvie Main Business Overview
11.7.5 Abbvie Latest Developments
11.8 Bausch Health
11.8.1 Bausch Health Company Information
11.8.2 Bausch Health Parkinson's Disease Treatments Product Offered
11.8.3 Bausch Health Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bausch Health Main Business Overview
11.8.5 Bausch Health Latest Developments
11.9 Lundbeck
11.9.1 Lundbeck Company Information
11.9.2 Lundbeck Parkinson's Disease Treatments Product Offered
11.9.3 Lundbeck Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Lundbeck Main Business Overview
11.9.5 Lundbeck Latest Developments
11.10 Sun Pharma
11.10.1 Sun Pharma Company Information
11.10.2 Sun Pharma Parkinson's Disease Treatments Product Offered
11.10.3 Sun Pharma Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Sun Pharma Main Business Overview
11.10.5 Sun Pharma Latest Developments
11.11 Wockhardt
11.11.1 Wockhardt Company Information
11.11.2 Wockhardt Parkinson's Disease Treatments Product Offered
11.11.3 Wockhardt Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Wockhardt Main Business Overview
11.11.5 Wockhardt Latest Developments
11.12 Acadia
11.12.1 Acadia Company Information
11.12.2 Acadia Parkinson's Disease Treatments Product Offered
11.12.3 Acadia Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Acadia Main Business Overview
11.12.5 Acadia Latest Developments
11.13 UCB
11.13.1 UCB Company Information
11.13.2 UCB Parkinson's Disease Treatments Product Offered
11.13.3 UCB Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 UCB Main Business Overview
11.13.5 UCB Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Parkinson's Disease Treatments Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Dopamine Agonists
Table 3. Major Players of Levodopa
Table 4. Major Players of Glutamate Antagonist
Table 5. Major Players of Apomorphine
Table 6. Major Players of COMT Inhibitors Anticholinergics
Table 7. Major Players of MAO-B Inhibitors
Table 8. Major Players of Other Drugs
Table 9. Parkinson's Disease Treatments Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Parkinson's Disease Treatments Market Size by Type (2019-2024) & ($ Millions)
Table 11. Global Parkinson's Disease Treatments Market Size Market Share by Type (2019-2024)
Table 12. Parkinson's Disease Treatments Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 13. Global Parkinson's Disease Treatments Market Size by Application (2019-2024) & ($ Millions)
Table 14. Global Parkinson's Disease Treatments Market Size Market Share by Application (2019-2024)
Table 15. Global Parkinson's Disease Treatments Revenue by Players (2019-2024) & ($ Millions)
Table 16. Global Parkinson's Disease Treatments Revenue Market Share by Player (2019-2024)
Table 17. Parkinson's Disease Treatments Key Players Head office and Products Offered
Table 18. Parkinson's Disease Treatments Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Parkinson's Disease Treatments Market Size by Regions 2019-2024 & ($ Millions)
Table 22. Global Parkinson's Disease Treatments Market Size Market Share by Regions (2019-2024)
Table 23. Global Parkinson's Disease Treatments Revenue by Country/Region (2019-2024) & ($ millions)
Table 24. Global Parkinson's Disease Treatments Revenue Market Share by Country/Region (2019-2024)
Table 25. Americas Parkinson's Disease Treatments Market Size by Country (2019-2024) & ($ Millions)
Table 26. Americas Parkinson's Disease Treatments Market Size Market Share by Country (2019-2024)
Table 27. Americas Parkinson's Disease Treatments Market Size by Type (2019-2024) & ($ Millions)
Table 28. Americas Parkinson's Disease Treatments Market Size Market Share by Type (2019-2024)
Table 29. Americas Parkinson's Disease Treatments Market Size by Application (2019-2024) & ($ Millions)
Table 30. Americas Parkinson's Disease Treatments Market Size Market Share by Application (2019-2024)
Table 31. APAC Parkinson's Disease Treatments Market Size by Region (2019-2024) & ($ Millions)
Table 32. APAC Parkinson's Disease Treatments Market Size Market Share by Region (2019-2024)
Table 33. APAC Parkinson's Disease Treatments Market Size by Type (2019-2024) & ($ Millions)
Table 34. APAC Parkinson's Disease Treatments Market Size Market Share by Type (2019-2024)
Table 35. APAC Parkinson's Disease Treatments Market Size by Application (2019-2024) & ($ Millions)
Table 36. APAC Parkinson's Disease Treatments Market Size Market Share by Application (2019-2024)
Table 37. Europe Parkinson's Disease Treatments Market Size by Country (2019-2024) & ($ Millions)
Table 38. Europe Parkinson's Disease Treatments Market Size Market Share by Country (2019-2024)
Table 39. Europe Parkinson's Disease Treatments Market Size by Type (2019-2024) & ($ Millions)
Table 40. Europe Parkinson's Disease Treatments Market Size Market Share by Type (2019-2024)
Table 41. Europe Parkinson's Disease Treatments Market Size by Application (2019-2024) & ($ Millions)
Table 42. Europe Parkinson's Disease Treatments Market Size Market Share by Application (2019-2024)
Table 43. Middle East & Africa Parkinson's Disease Treatments Market Size by Region (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Parkinson's Disease Treatments Market Size Market Share by Region (2019-2024)
Table 45. Middle East & Africa Parkinson's Disease Treatments Market Size by Type (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Parkinson's Disease Treatments Market Size Market Share by Type (2019-2024)
Table 47. Middle East & Africa Parkinson's Disease Treatments Market Size by Application (2019-2024) & ($ Millions)
Table 48. Middle East & Africa Parkinson's Disease Treatments Market Size Market Share by Application (2019-2024)
Table 49. Key Market Drivers & Growth Opportunities of Parkinson's Disease Treatments
Table 50. Key Market Challenges & Risks of Parkinson's Disease Treatments
Table 51. Key Industry Trends of Parkinson's Disease Treatments
Table 52. Global Parkinson's Disease Treatments Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 53. Global Parkinson's Disease Treatments Market Size Market Share Forecast by Regions (2025-2030)
Table 54. Global Parkinson's Disease Treatments Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 55. Global Parkinson's Disease Treatments Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 56. GSK Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 57. GSK Parkinson's Disease Treatments Product Offered
Table 58. GSK Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. GSK Main Business
Table 60. GSK Latest Developments
Table 61. Merck Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 62. Merck Parkinson's Disease Treatments Product Offered
Table 63. Merck Main Business
Table 64. Merck Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Merck Latest Developments
Table 66. Novartis Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 67. Novartis Parkinson's Disease Treatments Product Offered
Table 68. Novartis Main Business
Table 69. Novartis Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Novartis Latest Developments
Table 71. Teva Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 72. Teva Parkinson's Disease Treatments Product Offered
Table 73. Teva Main Business
Table 74. Teva Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Teva Latest Developments
Table 76. Boehringer Ingelheim Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 77. Boehringer Ingelheim Parkinson's Disease Treatments Product Offered
Table 78. Boehringer Ingelheim Main Business
Table 79. Boehringer Ingelheim Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Boehringer Ingelheim Latest Developments
Table 81. Impax Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 82. Impax Parkinson's Disease Treatments Product Offered
Table 83. Impax Main Business
Table 84. Impax Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Impax Latest Developments
Table 86. Abbvie Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 87. Abbvie Parkinson's Disease Treatments Product Offered
Table 88. Abbvie Main Business
Table 89. Abbvie Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Abbvie Latest Developments
Table 91. Bausch Health Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 92. Bausch Health Parkinson's Disease Treatments Product Offered
Table 93. Bausch Health Main Business
Table 94. Bausch Health Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Bausch Health Latest Developments
Table 96. Lundbeck Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 97. Lundbeck Parkinson's Disease Treatments Product Offered
Table 98. Lundbeck Main Business
Table 99. Lundbeck Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Lundbeck Latest Developments
Table 101. Sun Pharma Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 102. Sun Pharma Parkinson's Disease Treatments Product Offered
Table 103. Sun Pharma Main Business
Table 104. Sun Pharma Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Sun Pharma Latest Developments
Table 106. Wockhardt Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 107. Wockhardt Parkinson's Disease Treatments Product Offered
Table 108. Wockhardt Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 109. Wockhardt Main Business
Table 110. Wockhardt Latest Developments
Table 111. Acadia Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 112. Acadia Parkinson's Disease Treatments Product Offered
Table 113. Acadia Main Business
Table 114. Acadia Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Acadia Latest Developments
Table 116. UCB Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 117. UCB Parkinson's Disease Treatments Product Offered
Table 118. UCB Main Business
Table 119. UCB Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. UCB Latest Developments
Table 1. Parkinson's Disease Treatments Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Dopamine Agonists
Table 3. Major Players of Levodopa
Table 4. Major Players of Glutamate Antagonist
Table 5. Major Players of Apomorphine
Table 6. Major Players of COMT Inhibitors Anticholinergics
Table 7. Major Players of MAO-B Inhibitors
Table 8. Major Players of Other Drugs
Table 9. Parkinson's Disease Treatments Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Parkinson's Disease Treatments Market Size by Type (2019-2024) & ($ Millions)
Table 11. Global Parkinson's Disease Treatments Market Size Market Share by Type (2019-2024)
Table 12. Parkinson's Disease Treatments Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 13. Global Parkinson's Disease Treatments Market Size by Application (2019-2024) & ($ Millions)
Table 14. Global Parkinson's Disease Treatments Market Size Market Share by Application (2019-2024)
Table 15. Global Parkinson's Disease Treatments Revenue by Players (2019-2024) & ($ Millions)
Table 16. Global Parkinson's Disease Treatments Revenue Market Share by Player (2019-2024)
Table 17. Parkinson's Disease Treatments Key Players Head office and Products Offered
Table 18. Parkinson's Disease Treatments Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Parkinson's Disease Treatments Market Size by Regions 2019-2024 & ($ Millions)
Table 22. Global Parkinson's Disease Treatments Market Size Market Share by Regions (2019-2024)
Table 23. Global Parkinson's Disease Treatments Revenue by Country/Region (2019-2024) & ($ millions)
Table 24. Global Parkinson's Disease Treatments Revenue Market Share by Country/Region (2019-2024)
Table 25. Americas Parkinson's Disease Treatments Market Size by Country (2019-2024) & ($ Millions)
Table 26. Americas Parkinson's Disease Treatments Market Size Market Share by Country (2019-2024)
Table 27. Americas Parkinson's Disease Treatments Market Size by Type (2019-2024) & ($ Millions)
Table 28. Americas Parkinson's Disease Treatments Market Size Market Share by Type (2019-2024)
Table 29. Americas Parkinson's Disease Treatments Market Size by Application (2019-2024) & ($ Millions)
Table 30. Americas Parkinson's Disease Treatments Market Size Market Share by Application (2019-2024)
Table 31. APAC Parkinson's Disease Treatments Market Size by Region (2019-2024) & ($ Millions)
Table 32. APAC Parkinson's Disease Treatments Market Size Market Share by Region (2019-2024)
Table 33. APAC Parkinson's Disease Treatments Market Size by Type (2019-2024) & ($ Millions)
Table 34. APAC Parkinson's Disease Treatments Market Size Market Share by Type (2019-2024)
Table 35. APAC Parkinson's Disease Treatments Market Size by Application (2019-2024) & ($ Millions)
Table 36. APAC Parkinson's Disease Treatments Market Size Market Share by Application (2019-2024)
Table 37. Europe Parkinson's Disease Treatments Market Size by Country (2019-2024) & ($ Millions)
Table 38. Europe Parkinson's Disease Treatments Market Size Market Share by Country (2019-2024)
Table 39. Europe Parkinson's Disease Treatments Market Size by Type (2019-2024) & ($ Millions)
Table 40. Europe Parkinson's Disease Treatments Market Size Market Share by Type (2019-2024)
Table 41. Europe Parkinson's Disease Treatments Market Size by Application (2019-2024) & ($ Millions)
Table 42. Europe Parkinson's Disease Treatments Market Size Market Share by Application (2019-2024)
Table 43. Middle East & Africa Parkinson's Disease Treatments Market Size by Region (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Parkinson's Disease Treatments Market Size Market Share by Region (2019-2024)
Table 45. Middle East & Africa Parkinson's Disease Treatments Market Size by Type (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Parkinson's Disease Treatments Market Size Market Share by Type (2019-2024)
Table 47. Middle East & Africa Parkinson's Disease Treatments Market Size by Application (2019-2024) & ($ Millions)
Table 48. Middle East & Africa Parkinson's Disease Treatments Market Size Market Share by Application (2019-2024)
Table 49. Key Market Drivers & Growth Opportunities of Parkinson's Disease Treatments
Table 50. Key Market Challenges & Risks of Parkinson's Disease Treatments
Table 51. Key Industry Trends of Parkinson's Disease Treatments
Table 52. Global Parkinson's Disease Treatments Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 53. Global Parkinson's Disease Treatments Market Size Market Share Forecast by Regions (2025-2030)
Table 54. Global Parkinson's Disease Treatments Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 55. Global Parkinson's Disease Treatments Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 56. GSK Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 57. GSK Parkinson's Disease Treatments Product Offered
Table 58. GSK Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. GSK Main Business
Table 60. GSK Latest Developments
Table 61. Merck Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 62. Merck Parkinson's Disease Treatments Product Offered
Table 63. Merck Main Business
Table 64. Merck Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Merck Latest Developments
Table 66. Novartis Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 67. Novartis Parkinson's Disease Treatments Product Offered
Table 68. Novartis Main Business
Table 69. Novartis Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Novartis Latest Developments
Table 71. Teva Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 72. Teva Parkinson's Disease Treatments Product Offered
Table 73. Teva Main Business
Table 74. Teva Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Teva Latest Developments
Table 76. Boehringer Ingelheim Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 77. Boehringer Ingelheim Parkinson's Disease Treatments Product Offered
Table 78. Boehringer Ingelheim Main Business
Table 79. Boehringer Ingelheim Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Boehringer Ingelheim Latest Developments
Table 81. Impax Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 82. Impax Parkinson's Disease Treatments Product Offered
Table 83. Impax Main Business
Table 84. Impax Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Impax Latest Developments
Table 86. Abbvie Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 87. Abbvie Parkinson's Disease Treatments Product Offered
Table 88. Abbvie Main Business
Table 89. Abbvie Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Abbvie Latest Developments
Table 91. Bausch Health Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 92. Bausch Health Parkinson's Disease Treatments Product Offered
Table 93. Bausch Health Main Business
Table 94. Bausch Health Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Bausch Health Latest Developments
Table 96. Lundbeck Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 97. Lundbeck Parkinson's Disease Treatments Product Offered
Table 98. Lundbeck Main Business
Table 99. Lundbeck Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Lundbeck Latest Developments
Table 101. Sun Pharma Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 102. Sun Pharma Parkinson's Disease Treatments Product Offered
Table 103. Sun Pharma Main Business
Table 104. Sun Pharma Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Sun Pharma Latest Developments
Table 106. Wockhardt Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 107. Wockhardt Parkinson's Disease Treatments Product Offered
Table 108. Wockhardt Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 109. Wockhardt Main Business
Table 110. Wockhardt Latest Developments
Table 111. Acadia Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 112. Acadia Parkinson's Disease Treatments Product Offered
Table 113. Acadia Main Business
Table 114. Acadia Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Acadia Latest Developments
Table 116. UCB Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors
Table 117. UCB Parkinson's Disease Treatments Product Offered
Table 118. UCB Main Business
Table 119. UCB Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. UCB Latest Developments
LIST OF FIGURES
Figure 1. Parkinson's Disease Treatments Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Parkinson's Disease Treatments Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Parkinson's Disease Treatments Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Parkinson's Disease Treatments Sales Market Share by Country/Region (2023)
Figure 8. Parkinson's Disease Treatments Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Parkinson's Disease Treatments Market Size Market Share by Type in 2023
Figure 10. Parkinson's Disease Treatments in Hospitals
Figure 11. Global Parkinson's Disease Treatments Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Parkinson's Disease Treatments in Healthcare Institutes
Figure 13. Global Parkinson's Disease Treatments Market: Healthcare Institutes (2019-2024) & ($ Millions)
Figure 14. Parkinson's Disease Treatments in Others
Figure 15. Global Parkinson's Disease Treatments Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Parkinson's Disease Treatments Market Size Market Share by Application in 2023
Figure 17. Global Parkinson's Disease Treatments Revenue Market Share by Player in 2023
Figure 18. Global Parkinson's Disease Treatments Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Parkinson's Disease Treatments Market Size 2019-2024 ($ Millions)
Figure 20. APAC Parkinson's Disease Treatments Market Size 2019-2024 ($ Millions)
Figure 21. Europe Parkinson's Disease Treatments Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Parkinson's Disease Treatments Market Size 2019-2024 ($ Millions)
Figure 23. Americas Parkinson's Disease Treatments Value Market Share by Country in 2023
Figure 24. United States Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Parkinson's Disease Treatments Market Size Market Share by Region in 2023
Figure 29. APAC Parkinson's Disease Treatments Market Size Market Share by Type in 2023
Figure 30. APAC Parkinson's Disease Treatments Market Size Market Share by Application in 2023
Figure 31. China Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Parkinson's Disease Treatments Market Size Market Share by Country in 2023
Figure 38. Europe Parkinson's Disease Treatments Market Size Market Share by Type (2019-2024)
Figure 39. Europe Parkinson's Disease Treatments Market Size Market Share by Application (2019-2024)
Figure 40. Germany Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Parkinson's Disease Treatments Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Parkinson's Disease Treatments Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Parkinson's Disease Treatments Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 54. APAC Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 55. Europe Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 57. United States Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 58. Canada Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 61. China Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 62. Japan Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 63. Korea Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 65. India Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 66. Australia Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 67. Germany Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 68. France Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 69. UK Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 70. Italy Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 71. Russia Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 72. Spain Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 75. Israel Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 78. Global Parkinson's Disease Treatments Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Parkinson's Disease Treatments Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Parkinson's Disease Treatments Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Parkinson's Disease Treatments Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Parkinson's Disease Treatments Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Parkinson's Disease Treatments Sales Market Share by Country/Region (2023)
Figure 8. Parkinson's Disease Treatments Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Parkinson's Disease Treatments Market Size Market Share by Type in 2023
Figure 10. Parkinson's Disease Treatments in Hospitals
Figure 11. Global Parkinson's Disease Treatments Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Parkinson's Disease Treatments in Healthcare Institutes
Figure 13. Global Parkinson's Disease Treatments Market: Healthcare Institutes (2019-2024) & ($ Millions)
Figure 14. Parkinson's Disease Treatments in Others
Figure 15. Global Parkinson's Disease Treatments Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Parkinson's Disease Treatments Market Size Market Share by Application in 2023
Figure 17. Global Parkinson's Disease Treatments Revenue Market Share by Player in 2023
Figure 18. Global Parkinson's Disease Treatments Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Parkinson's Disease Treatments Market Size 2019-2024 ($ Millions)
Figure 20. APAC Parkinson's Disease Treatments Market Size 2019-2024 ($ Millions)
Figure 21. Europe Parkinson's Disease Treatments Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Parkinson's Disease Treatments Market Size 2019-2024 ($ Millions)
Figure 23. Americas Parkinson's Disease Treatments Value Market Share by Country in 2023
Figure 24. United States Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Parkinson's Disease Treatments Market Size Market Share by Region in 2023
Figure 29. APAC Parkinson's Disease Treatments Market Size Market Share by Type in 2023
Figure 30. APAC Parkinson's Disease Treatments Market Size Market Share by Application in 2023
Figure 31. China Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Parkinson's Disease Treatments Market Size Market Share by Country in 2023
Figure 38. Europe Parkinson's Disease Treatments Market Size Market Share by Type (2019-2024)
Figure 39. Europe Parkinson's Disease Treatments Market Size Market Share by Application (2019-2024)
Figure 40. Germany Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Parkinson's Disease Treatments Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Parkinson's Disease Treatments Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Parkinson's Disease Treatments Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Parkinson's Disease Treatments Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 54. APAC Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 55. Europe Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 57. United States Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 58. Canada Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 61. China Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 62. Japan Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 63. Korea Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 65. India Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 66. Australia Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 67. Germany Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 68. France Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 69. UK Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 70. Italy Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 71. Russia Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 72. Spain Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 75. Israel Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Parkinson's Disease Treatments Market Size 2025-2030 ($ Millions)
Figure 78. Global Parkinson's Disease Treatments Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Parkinson's Disease Treatments Market Size Market Share Forecast by Application (2025-2030)
